Table 1 Comparison between patients who died within 30 days of bacteremia diagnosis and patients who survived
Full cohort n(%) | Died within 30 days n (%) | Survived n (%) | Odds ratio | 95% CI | P | |
|---|---|---|---|---|---|---|
Total | 62 | 8(100) | 54(100) | |||
Gender (male) | 40 (64.5) | 6 (75.0) | 34 (63.0) | 0.512 | ||
Age, median (years) | 69 (range; 1–92) | 76 (range; 52–86) | 69 (range; 1–92) | 0.126 | ||
Duration from admission to bacteremia, median (days) | 17 (range; 3–142) | 33(range; 9–142) | 16(range; 3–86) | 0.089 | ||
Duration of antibiotic therapy from diagnosis of PVC-BSI, median (days) | 16 (range; 5–100) | 17(range; 7–46) | 16(range; 3–100) | 0.737 | ||
Time from catheter insertion to bacteremia, median (days) | 6 (range; 2–15) | 7 (range; 2–9) | 7 (range; 3–15) | 0.526 | ||
Unknown | 26 (41.9) | 2 (25.0) | 24 (44.4) | 0.42 | 0.08–2.25 | 0.298 |
< 3 days | 4 (11.1) | 2 (25.0) | 2 (3.7) | 8.67 | 1.03–73.25 | 0.022 |
4–7 days | 19 (52.8) | 1(16.7) | 18 (66.7) | 0.29 | 0.03–2.50 | 0.232 |
> 8 days | 13 (36.1) | 3(50.0) | 10 (30.0) | 2.64 | 0.54–12.91 | 0.218 |
Causative microorganism (including duplicate polymicrobials) | ||||||
Gram-positive microorganisms | 47(58.0) | 7(77.8) | 40(54.8) | 2.45 | 0.28–21.72 | 0.408 |
S.aureus | 14(17.3) | 5(62.5) | 9(16.7) | 8.33 | 1.68–41.29 | 0.004 |
MSSA | 10(71.4) | 3(37.5) | 7(12.7) | 4.03 | 0.78–20.70 | 0.078 |
MRSA | 4(28.6) | 2(25.0) | 2(3.7) | 8.67 | 1.03–73.25 | 0.022 |
CNS | 21(25.9) | 2(25.0) | 16(29.6) | 0.79 | 0.14–4.35 | 0.788 |
Bacillus spp. | 6(7.4) | 0 | 6(11.1) | 0.44 | 0.02–8.53 | 0.576 |
Enterococcus spp. | 6(7.4) | 0 | 6(11.1) | 0.44 | 0.02–8.53 | 0.576 |
Gram-negative microorganisms | 30(35.8) | 2(22.2) | 28(38.4) | 0.31 | 0.06–1.67 | 0.156 |
Enterobacter spp. | 9(11.1) | 0 | 6(11.1) | 0.44 | 0.02–8.53 | 0.576 |
Klebsiella spp. | 5(6.2) | 1(12.5) | 4(7.4) | 1.79 | 0.17–18.35 | 0.621 |
Pseudomonus spp. | 4(4.9) | 1(12.5) | 3(5.6) | 2.43 | 0.22–26.69 | 0.455 |
Acinetobacter spp. | 4(4.9) | 0 | 4(7.4) | 0.66 | 0.03–13.40 | 0.785 |
Serratia spp. | 4(4.9) | 0 | 4(7.4) | 0.66 | 0.03–13.40 | 0.785 |
E.coli | 3(3.7) | 0 | 3(5.6) | 0.87 | 0.04–18.29 | 0.926 |
Citrobacter spp. | 1(1.2) | 0 | 1(1.9) | 2.10 | 0.08–55.84 | 0.651 |
Candida spp. | 5(6.2) | 0(0.0) | 5(6.8) | 0.53 | 0.03–10.48 | 0.671 |
Polymicrobial | 16(25.8) | 1(12.5) | 15(27.8) | 0.37 | 0.04–3.28 | 0.357 |
Underlying diseases (including duplicate) | ||||||
Malignancy | 33 (53.2) | 4(50.0) | 26(48.1) | 1.08 | 0.24–4.76 | 0.922 |
Hypertension | 14 (22.6) | 0 | 14 | 0.16 | 0.01–0.03 | 0.172 |
Diabetes mellitus | 11 (17.7) | 0 | 11 | 0.22 | 0.01–4.15 | 0.274 |
Cerebral infarction | 7 (11.3) | 2(25.0) | 5(9.3) | 3.27 | 0.52–20.69 | 0.189 |
Orthopedic disorder | 3 (4.8) | 0 | 3 (5.6) | 0.87 | 0.04–18.29 | 0.926 |
Department | ||||||
Surgery | 35 (56.5) | 3(37.5) | 32(59.3) | 0.41 | 0.09–1.91 | 0.247 |
Internal medicine | 21 (33.9) | 5(62.5) | 16(29.6) | 3.96 | 0.84–18.57 | 0.067 |
Obstetrics and Gynecology | 5 (8.1) | 0 | 5 (9.3) | 0.53 | 0.03–10.48 | 0.672 |
Pediatrics | 1 (1.6) | 0 | 1 (1.9) | 2.10 | 0.08–55.84 | 0.651 |
Place of insertion | ||||||
Arm | 48 (77.4) | 7 (87.5) | 41 (75.9) | 2.22 | 0.25–19.76 | 0.465 |
Foot | 3 (4.8) | 1(12.5) | 2 (3.7) | 3.71 | 0.30–46.48 | 0.279 |
Unknown | 11 (17.7) | 0 | 11 (20.4) | 0.22 | 0.01–4.15 | 0.274 |
Complication | ||||||
Suppurative thrombophlebitis | 18 (29.0) | 3(37.5) | 15(27.8) | 1.56 | 0.33–7.35 | 0.572 |
Bacterial cellulitis | 3 (4.8) | 2 (25.0) | 1 (1.8) | 17.67 | 1.39–225.05 | 0.004 |
Osteomyelitis | 2 (3.2) | 0 | 2 (3.7) | 1.24 | 0.05–28.02 | 0.894 |